Detalhe da pesquisa
1.
EZH2 cooperates with gain-of-function p53 mutants to promote cancer growth and metastasis.
EMBO J
; 38(5)2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30723117
2.
Metastasis-directed Therapy Without Androgen Deprivation Therapy in Solitary Oligorecurrent Prostate Cancer.
J Urol
; 208(6): 1240-1249, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36349914
3.
Pubectomy and urinary reconstruction provides definitive treatment of urosymphyseal fistula following prostate cancer treatment.
BJU Int
; 128(4): 460-467, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33403768
4.
Evaluation of predictive model performance of an existing model in the presence of missing data.
Stat Med
; 40(15): 3477-3498, 2021 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33843085
5.
Kallikrein markers performance in pretreatment blood to predict early prostate cancer recurrence and metastasis after radical prostatectomy among very high-risk men.
Prostate
; 80(1): 51-56, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31603253
6.
Risk Stratification of Patients with Recurrence After Primary Treatment for Prostate Cancer: A Systematic Review.
Eur Urol
; 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38782697
7.
A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER).
Eur Urol
; 80(3): 280-292, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33309278
8.
Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a de novo low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer.
Clin Cancer Res
; 25(22): 6721-6730, 2019 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31515456
9.
BMI1 polycomb group protein acts as a master switch for growth and death of tumor cells: regulates TCF4-transcriptional factor-induced BCL2 signaling.
PLoS One
; 8(5): e60664, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23671559
10.
BMI1, stem cell factor acting as novel serum-biomarker for Caucasian and African-American prostate cancer.
PLoS One
; 8(1): e52993, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23308129
11.
Lupeol, a novel androgen receptor inhibitor: implications in prostate cancer therapy.
Clin Cancer Res
; 17(16): 5379-91, 2011 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21712449